William Reardon - Tekla Life Insider

XHQLX -- USA Fund  

USD 21.10  0.04  0.19%

Independent Trustee
Mr. William S. Reardon CPA is Independent Trustee of HQ Life Sciences Investors. Mr. Reardon personal experience as a Life Science audit partner at PricewaterhouseCoopers LLP, with a broad spectrum of companies across the corporate life cycle from startup to successful product driven pharmaceutical companies, provides each Fund with a valuable perspective in analyzing life science company opportunities and in valuing the venture portion of the portfolio. Until 2002, Mr. Reardon was a business assurance partner in PwC Boston office and leader of the Life Sciences Industry Practice for New England and the Eastern U.S., working closely with many of the Firm public clients in SECregistered equity, convertible and RD limited partnership offerings and many initial public offerings. He serves on the Valuation and Audit Committees of each Fund. From 19982000 he served on the Board of the Emerging Companies Section of the Biotechnology Industry Organization and from 2000 to 2002 he served on the Board of Directors of the Massachusetts Biotechnology Council . During his professional career, he was a frequent speaker at BIO conferences and MBC Industry meetings on issues affecting biotechnology companies. He currently also serves as a board member and audit committee chair of two developmentstage public companies, Synta Pharmaceuticals and Idera Pharmaceuticals
Age: 70  Executive Since 2010  CPA    
Reardon is member of the American Institute of CPAs and the Massachusetts Society of CPAs, with an MBA from Harvard Business School and a BA in East Asian History from Harvard College.

William Reardon Latest Insider Activity

Management Performance (%)

Similar Money Managers

Found 10 records

One Year Return

Barbara MillerJPMorgan Core Bond R4
Pablo MataMFS International Value B
Andrew DierdorfFidelity Freedom 2030 K
Andrew OBrienLord Abbett Short Duration Inco
Matthew McLennanFirst Eagle Global Fund Class R
Spiros SegalasHarbor Capital Appreciation Ret
Andrew DierdorfFidelity Freedom 2020 K
John SmetAmerican Funds Bond Fund of Ame
Andrew OBrienLord Abbett Short Duration Inco
Dina PerryAmerican Funds Fundamental Inve

Fund Summary

The fund is listed under null category and is part of null family.

Tekla Life Sciences Leadership Team

William Reardon, Executive, CPA
Michael Bonney, Executive